Document is current
Any future updates will be listed below
-
Authors
Villani, Edoardo https://orcid.org/0000-0003-3811-5893
Campagna, Giuseppe
Gentili, Valentina
Postorino, Elisa Imelde
Genovese, Paola
Palino, Paola
Maini, Gloria
Carbucicchio, Alice
Ferioli, Eleonora
Nucci, Paolo
Rizzo, Roberta
Aragona, Pasquale
-
Funding
Funding for this research was provided by:
FB Vision (Unnumbered, Unnumbered, Unnumbered, Unnumbered)
- License Information
-
More Information
Article History
Received: 19 October 2024
Accepted: 28 January 2025
First Online: 1 March 2025
Declarations
:
: Edoardo Villani has received honoraria from AbbVie, Alcon, Diadema, FB Vision, Fidia, Essilor Luxottica, NTC, Santen, Sifi, Thea, Unifarco, Visufarma for contributing to advisory boards, educational events, and/or expert panels. Pasquale Aragona has received honoraria from AbbVie, Alcon, Bausch and Lomb, DMG, FB Vision, Fidia, Medivis, Santen, Sifi, Sun Pharma, Thea for contributing to advisory boards, educational events, and/or expert panels. Giuseppe Campagna, Valentina Gentili, Elisa Imelde Postorino, Paola Genovese, Paola Palino, Gloria Maini, Alice Carbucicchio, Eleonora Ferioli, Paolo Nucci, and Roberta Rizzo declare that they have no competing interests.
: The clinical study was approved by Intercompany Ethics Committee of Messina (Italy), protocol number: Prot. 20–22, and was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All subjects included provided informed consent to participate in the study.
